Bio-Rad Laboratories | BIO - Capitaux D'Emprunt





Capitaux D'Emprunt Changement Date
Abbott USD 29.64B 19.74B 2026-03
Agilent USD 3.05B 1000K 2026-03
Becton, Dickinson and Co. USD 14.71B 2.21B 2026-03
Bio Techne USD 200M 60M 2026-03
Bio-Rad Laboratories USD 802.9M 398.8M 2026-03
Bruker USD 1.66B 189.6M 2026-03
Charles River Laboratories USD 2.66B 526.77M 2026-03
Danaher USD 17.56B 855M 2026-03
General Electric Aerospace USD 18.17B 634M 2026-03
Illumina USD 1.49B 0 2026-03
IQVIA Holdings USD 13.99B 105M 2026-03
Laboratory Of America USD 5.9B 748.3M 2026-03
Merck USD 46.67B 77M 2026-03
Mettler Toledo International USD 2.16B 73.35M 2026-03
Myriad Genetics USD 120.3M 400K 2026-03
OraSure Technologies USD 100K 17K 2025-12
Pacific Biosciences Of California USD 645.38M 223K 2025-12
Quest Diagnostics USD 5.16B 12M 2026-03
Repligen USD 546.58M 4.37M 2026-03
Revvity USD 2.63B 836K 2026-03
Roche Holding CHF 27.43B 966M 2025-12
Siemens EUR 41.52B 1.31B 2026-03
Standard Biotools USD 299K 0 2026-03
Thermo Fisher Scientific USD 40.07B 4.22B 2026-03
Tosoh JPY 84.23B 9.84B 2026-03
Waters USD 5.22B 3.81B 2026-03